Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -611 | -1,093 | 127 | -2,108 | -296 |
| Depreciation Amortization | 214 | 587 | 273 | 271 | 146 |
| Accounts receivable | -4,204 | -4,605 | -3,919 | -3,374 | -2,222 |
| Other Working Capital | -5,357 | -2,653 | -2,856 | -1,795 | -2,466 |
| Other Operating Activity | 4,388 | -5,505 | -2,032 | -76 | 253 |
| Operating Cash Flow | $-5,570 | $-13,269 | $-8,407 | $-7,082 | $-4,585 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,000 | -7,283 | 5,705 | 6,546 | 3,971 |
| PPE Investments | -127 | -528 | -454 | -298 | -111 |
| Net Acquisitions | N/A | 19,419 | N/A | N/A | N/A |
| Investing Cash Flow | $4,873 | $11,608 | $5,251 | $6,248 | $3,860 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11 | -44 | -33 | -22 | -11 |
| Common Stock Issued | 634 | 2,193 | 3,062 | 581 | 169 |
| Other Financing Activity | 0 | 74 | 74 | 0 | 0 |
| Financing Cash Flow | $623 | $2,223 | $3,103 | $559 | $158 |
| Beginning Cash Position | 2,416 | 1,854 | 1,854 | 1,854 | 1,854 |
| End Cash Position | 2,342 | 2,416 | 1,801 | 1,579 | 1,287 |
| Net Cash Flow | $-74 | $562 | $-53 | $-275 | $-567 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,570 | -13,269 | -8,407 | -7,082 | -4,585 |
| Capital Expenditure | -127 | -528 | -454 | -298 | -111 |
| Free Cash Flow | -5,697 | -13,797 | -8,861 | -7,380 | -4,696 |